These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31497026)

  • 21. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic applications of selenium nanoparticles.
    Khurana A; Tekula S; Saifi MA; Venkatesh P; Godugu C
    Biomed Pharmacother; 2019 Mar; 111():802-812. PubMed ID: 30616079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
    Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
    Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
    Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-responsive functional Ru nanoparticles combining a tumor-associated macrophage repolarization strategy with phototherapy for colorectal cancer therapy.
    Liu Y; Wen Y; Chen X; Zhu X; Yu Q; Gong Y; Yuan G; Liu J; Qin X
    J Mater Chem B; 2019 Oct; 7(40):6210-6223. PubMed ID: 31566200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.
    Park S; Kang S; Chen X; Kim EJ; Kim J; Kim N; Kim J; Jin MM
    Biomaterials; 2013 Jan; 34(2):598-605. PubMed ID: 23099063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
    Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
    J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
    Thierry B
    Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage: Hidden Criminal in Therapy Resistance.
    Ding Y; Cao Q; Yang W; Xu J; Xiao P
    J Innate Immun; 2024; 16(1):188-202. PubMed ID: 38442696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in nanomedicine towards clinical application in oncology and immunology.
    Herreros E; Morales S; Cortés C; Cabaña M; Peñaloza JP; Jara L; Geraldo D; Otero C; Fernández-Ramires R
    Curr Pharm Biotechnol; 2014; 15(9):864-79. PubMed ID: 25213311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actively targeted nanocarriers for drug delivery to cancer cells.
    Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulatory Nanomedicine.
    Bartneck M
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28383783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting tumor associated macrophages (TAMs) via nanocarriers.
    Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
    J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.